Acting on its own, as well as frequently drawing upon broader Greater China resources from the mainland, Wilson Sonsini Goodrich & Rosati is able to provide domestic and US securities law advice to Chinese issuers and international underwriters across a range of ECM/corporate finance work, including on HKEX IPOs, follow-on offerings, SPACs and de-SPACs. Unsurprisingly perhaps, given the firm’s historical and ongoing reputation as a Silicon Valley heavyweight, many of these mandates relate to growth industries including TMT, healthcare and life sciences. Splitting her time between the Hong Kong and Beijing offices, team head Dan Ouyang is pivotal to the team’s success.
Key clients
- Citigroup Global Markets
- China International Capital Corporation
Work highlights
- Advising Fenbi Ltd. on its $25.5m Hong Kong IPO.
- Advising TechStar Acquisition Corp. on $128.5m Hong Kong SPAC listing.